No Data
No Data
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $105.57
This Is Why You Should Turn Defensive, Underweight Cyclicals – UBS
Alcon's Late-Stage Pipeline Set To Drive Revenue Growth Next Year -- Market Talk
Alcon Top Pick for 2025 at Needham, Added to Conviction List
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Alcon (ALC) and Humana (HUM)
loading...